XML 62 R46.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Equity Awards and Instruments (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] |
Schedule of Stock-based Compensation Expense | Total stock‑based compensation expense was as follows:
| Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Bonus Plan expense (see Note 11) | $ | 23,121 |  |  | $ | 6,524 |  |  | $ | — |
Restricted stock and RSUs expense (1) | 19,917 |  |  | 4,248 |  |  | 1,749 |
Stock option expense | 3,271 |  |  | 6,858 |  |  | 6,342 |
ESPP expense (see Note 13) | 2,118 |  |  | — |  |  | — |
Stock grants expense | 445 |  |  | 319 |  |  | — |
DCP elective participant deferrals expense (2) (see Note 12) | 173 |  |  | — |  |  | — |
IPO vested restricted stock and RSU expense | — |  |  | 15,102 |  |  | — |
Total stock-based compensation expense (3) | $ | 49,045 |  |  | $ | 33,051 |  |  | $ | 8,091 |
(1)Includes acquisition‑related shares (see Note 4). (2)DCP elective participant deferrals expense excludes deferred incentive bonus payable pursuant to the Bonus Plan. (3)As of December 31, 2021 and 2020, $6,749 and $6,835 remained in Accruals and other current liabilities in the consolidated balance sheets, respectively. Total stock‑based compensation expense is included in the consolidated statements of operations as follows:
| Year Ended December 31,
| 2021 |  | 2020 |  | 2019
Cost of subscriptions and licenses | $ | 1,442 |  |  | $ | 960 |  |  | $ | 115 |
Cost of services | 1,257 |  |  | 2,939 |  |  | 522 |
Research and development | 19,740 |  |  | 12,105 |  |  | 3,107 |
Selling and marketing | 5,980 |  |  | 6,692 |  |  | 2,210 |
General and administrative | 20,626 |  |  | 10,355 |  |  | 2,137 |
Total stock-based compensation expense | $ | 49,045 |  |  | $ | 33,051 |  |  | $ | 8,091 |
Schedule of Valuation Assumptions | The following weighted average assumptions were used in the Black‑Scholes option pricing model to estimate the fair values of stock options granted during the years ended December 31, 2020 and 2019. The Company did not grant stock options during the year ended December 31, 2021.
| Year Ended December 31,
| 2020 |  | 2019
Expected volatility | 31.04% |  | 29.57%
Expected dividend yield | 1.11% |  | 1.38%
Risk-free interest rate | 1.31% |  | 2.48%
Expected term (in years) | 3.75 |  | 3.75
Weighted average grant date fair value of stock options issued | $2.49 |  | $1.66
Schedule of Options | The following is a summary of stock option activity and related information under the Company’s applicable equity incentive plans:
|  |  |  |  | Weighted |  |
|  |  | Weighted |  | Average |  |
|  |  | Average |  | Remaining |  | Aggregate
| Stock |  | Exercise Price |  | Contractual |  | Intrinsic
| Options |  | Per Share |  | Life (in years) |  | Value
Outstanding, December 31, 2020 | 12,842,226 |  |  | $ | 4.87 |  |  |  |  |
Exercised | (5,653,551) |  |  | 4.36 |  |  |  |  |
Forfeited | (270,750) |  |  | 5.56 |  |  |  |  |
Outstanding, December 31, 2021 | 6,917,925 |  |  | $ | 5.26 |  |  | 1.57 |  | $ | 297,933 |
Exercisable, December 31, 2021 | 3,837,800 |  |  | $ | 5.00 |  |  | 1.26 |  | $ | 166,305 |
Schedule of Restricted Stock and Restricted Stock Unit Activity | The following is a summary of unvested restricted stock and RSU activity and related information under the Company’s applicable equity incentive plans:
|  |  |  |  |  |  | Time- |  | Performance-
|  |  |  |  |  |  | Based |  | Based
|  |  | Time- |  | Performance- |  | Weighted |  | Weighted
| Total |  | Based |  | Based |  | Average |  | Average
| Restricted |  | Restricted |  | Restricted |  | Grant Date |  | Grant Date
| Stock |  | Stock |  | Stock |  | Fair Value |  | Fair Value
| and RSUs |  | and RSUs |  | and RSUs |  | Per Share |  | Per Share
Unvested, December 31, 2020 | 1,423,715 |  |  | 1,263,193 |  |  | 160,522 |  | (3) | $ | 16.38 |  |  | $ | 16.62 |
Granted | 894,595 |  | (1) | 794,787 |  |  | 99,808 |  | (4) | 52.80 |  | 49.93
Vested | (399,893) |  |  | (364,963) |  |  | (34,930) |  | (3) | 21.95 |  |  | 17.53 |
Forfeited | (209,872) |  |  | (81,155) |  |  | (128,717) |  |  | 22.00 |  |  | 17.18 |
Unvested, December 31, 2021 | 1,708,545 |  | (2) | 1,611,862 |  |  | 96,683 |  | (5) | $ | 32.81 |  |  | $ | 49.93 |
(1)For the year ended December 31, 2021, the Company granted RSUs only. (2)Includes 48,927 RSUs which are expected to be settled in cash. (3)Relates to the 2020 annual performance period. Total stock‑based compensation expense associated with these awards was fully recognized as of December 31, 2020. (4)Relates to the 2021 annual performance period. (5)Relates to the 2021 annual performance period. Total stock‑based compensation expense associated with these awards was fully recognized as of December 31, 2021.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration